Heng‐Huan Lee

The University of Texas MD Anderson Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 16 papers. Top paper: “TYRO3 induces anti–PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis”.

TYRO3 induces anti–PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis

Journal of Clinical Investigation(2021)10.1172/jci139434

N/A

7.4DataRank · unranked

314 citations

Seung-Oe Lim, Meisi Yan, Jennifer L. Hsu, Jun Yao, Yongkun Wei +12 more

The impact of PD-L1 N-linked glycosylation on cancer therapy and clinical diagnosis

Journal of Biomedical Science(2020)10.1186/s12929-020-00670-x

N/A

5.4DataRank · unranked

197 citations

Heng‐Huan Lee, Jennifer L. Hsu, Dihua Yu, Mien‐Chie Hung, Ying‐Nai Wang

TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphoma

Molecular Cancer(2022)10.1186/s12943-022-01655-0

N/A

2.1DataRank · unranked

76 citations

Dapeng Hao, Preetesh Jain, Yijing Li, Qingsong Cai, Yixin Yao +14 more

Ephrin receptor A10 monoclonal antibodies and the derived chimeric antigen receptor T cells exert an antitumor response in mouse models of triple-negative breast cancer

Journal of Biological Chemistry(2022)10.1016/j.jbc.2022.101817

N/A

0.815DataRank · unranked

21 citations

Li-Chuan Chan, Ying‐Nai Wang, Yu‐Yi Chu, Chie‐Hong Wang, Heng‐Huan Lee +17 more

The HSP90-MYC-CDK9 network drives therapeutic resistance in mantle cell lymphoma

Experimental Hematology and Oncology(2024)10.1186/s40164-024-00484-9

N/A

0.494DataRank · unranked

26 citations

Changying Jiang, Alexa A Jordan, Yuxuan Che, Yang Liu, Qingsong Cai +18 more

RNase1-driven ALK-activation is an oncogenic driver and therapeutic target in non-small cell lung cancer

Signal Transduction and Targeted Therapy(2025)10.1038/s41392-025-02206-x

N/A

0.327DataRank · unranked

6 citations

Chunxiao Liu, Meisi Yan, Cong Chen, Yu Cheng, Yaohui Chen +20 more

Ribonuclease 1 Enhances Antitumor Immunity against Breast Cancer by Boosting T cell Activation

International Journal of Biological Sciences(2023)10.7150/ijbs.84592

N/A

0DataRank · unranked

38 citations

Heng‐Huan Lee, Zhou Jiang, Li-Chuan Chan, Gabriel N. Hortobágyi, Dihua Yu +2 more

Cotargeting of BTK and MALT1 overcomes resistance to BTK inhibitors in mantle cell lymphoma

Journal of Clinical Investigation(2023)10.1172/jci165694

N/A

0DataRank · unranked

35 citations

Yang Liu, Junwei Lian, Shengjian Huang, Alexa A Jordan, Qingsong Cai +16 more

Novel Insights into SOX11 Modulation of BCR Signaling and Targeting of BTK Resistance

Blood(2024)10.1182/blood-2024-210591

N/A

0DataRank · unranked

1 citations

Heng‐Huan Lee, Ravi Prakash Shukla, Violetta V. Leshchenko, Fanye Meng, Fangfang Yan +7 more

TCA cycle mode switch determines the fate of pirtobrutinib-tolerant persister cells in mantle cell lymphoma

Blood(2025)10.1182/blood.2024026919

N/A

0DataRank · unranked

7 citations

Qingsong Cai, Yang Liu, Lei Nie, Heng‐Huan Lee, Fangfang Yan +24 more

SOX11 modulates BCR signaling through the PAX5/CD19 axis for therapeutic targeting in BTK-resistant mantle cell lymphoma

Blood Advances(2025)10.1182/bloodadvances.2025016801

N/A

0DataRank · unranked

3 citations

Heng‐Huan Lee, Violetta V. Leshchenko, Ravi Prakash Shukla, Fangfang Yan, Yang Liu +7 more

Targeting Glycosylated PD-1 Induces Potent Antitumor Immunity

Cancer Research(2020)10.1158/0008-5472.can-19-3133

N/A

0DataRank · unranked

174 citations

Chia-Wei Li, Ezra M. Chung, Ri‐Yao Yang, Yong‐Soo Kim, Andrew H Park +15 more

Ribonuclease 7-driven activation of ROS1 is a potential therapeutic target in hepatocellular carcinoma

Journal of Hepatology(2020)10.1016/j.jhep.2020.09.030

N/A

0DataRank · unranked

32 citations

Zhengyu Zha, Chenhao Zhou, Yeh Chen, Weiya Xia, Ying‐Nai Wang +14 more

Human ribonuclease 1 serves as a secretory ligand of ephrin A4 receptor and induces breast tumor initiation

Nature Communications(2021)10.1038/s41467-021-23075-2

N/A

0DataRank · unranked

31 citations

Ying‐Nai Wang, Wenhao Yang, Weiya Xia, Yongkun Wei, Li-Chuan Chan +25 more

Targeting the ALK–CDK9-Tyr19 kinase cascade sensitizes ovarian and breast tumors to PARP inhibition via destabilization of the P-TEFb complex

Nature Cancer(2022)10.1038/s43018-022-00438-2

N/A

0DataRank · unranked

37 citations

Mei‐Kuang Chen, Yongkun Wei, Heng‐Huan Lee, Weiya Xia, Ying‐Nai Wang +21 more

An optimized protocol for PD-L1 pathological assessment with patient sample deglycosylation to improve correlation with therapeutic response

STAR Protocols(2022)10.1016/j.xpro.2022.101198

N/A

0DataRank · unranked

9 citations

Heng‐Huan Lee, Yongkun Wei, Yu‐Yi Chu, Weiya Xia, Michael Wang +3 more